From Sample to Insight

QIAGEN Announces High Accuracy of Bioinformatics Solutions in Women’s Health Genetic Screening

QIAGEN bioinformatics and NGS solutions enable genomic breakthroughs

QIAGEN and CENTOGENE to collaborate in bioinformatics for genetic diseases

QIAGEN launches fourth-generation QuantiFERON®-TB Gold Plus in the U.S.

QIAGEN achieves ISO certification for state-of-the-art quality in forensics

QIAGEN N.V. announces successful completion of non-U.S. offer involving convertible notes

Ad-hoc announcement pursuant to Art. 17 MAR

QIAGEN and Clinical Genomics partner on liquid biopsies to monitor patients for recurrence of colorectal cancer

Disclosure according to Article 5 Section (1) and (6) of the EU Regulation 596/2014 (MAR) and the Delegated EU Regulation 2016/1052 / Share Repurchase

QIAGEN reports results for second quarter and first half of 2017